Analysis on Ethical Review of Clinical Stem-cell Research in Public Hospitals in China: Based on the Survey of 10 Public Hospitals in Shanghai, Tianjin and Guizhou

ZHANG Kan,MA Chenguang,WANG Jianping,BAI Lihua,LEI Ying,XUE Di
DOI: https://doi.org/10.12026/j.issn.1001-8565.2019.01.03
2019-01-01
Abstract:Objective: To analyze the ethical review of Clinical Stem-cell research in public hospitals in China. Methods: A questionnaire survey of related ethics committees was conducted among 10 public hospitals in Shanghai,Tianjin and Guizhou. Results: The ethical review of Clinical Stem-cell research basically grasped the elements of ethical review,but benefit and risk assessments were the difficult parts in ethical review,and risk disclosure was still insufficient. Conclusion: Ethics Committees in china should pay more attention to the trade-off between benefits and risks of Clinical Stem-cell research,specific risks of Clinical Stem-cell research and the improvement of ethical review elements of informed consent.
What problem does this paper attempt to address?